A 60-Year-Old Man With Progressive Anemia While Receiving Checkpoint Blockade Therapy for Relapsed Myelofibrosis

Oncology (Williston Park). 2017 Feb 15;31(2):122-4, 126-8.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anemia / chemically induced*
  • Antineoplastic Agents, Immunological / adverse effects*
  • Graft vs Host Disease / etiology
  • Hematopoietic Stem Cell Transplantation / adverse effects
  • Humans
  • Ipilimumab / adverse effects*
  • Male
  • Middle Aged
  • Primary Myelofibrosis / drug therapy*
  • Recurrence

Substances

  • Antineoplastic Agents, Immunological
  • Ipilimumab